The company valuation post merger will be an attractive takeover target imo. A reversal in the Spodumene price later this year and even more in 2026 will see a major rerate. Enough cash post merger to see further production growth just as Spodumene price surges.
The company valuation post merger will be an attractive takeover...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.002(14.3%) |
Mkt cap ! $167.3M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.6¢ | 1.4¢ | $371.3K | 24.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 4466775 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 17405173 | 65 |
View Market Depth
| Last trade - 14.19pm 20/06/2025 (20 minute delay) ? |
| SYA (ASX) Chart |